Regulation of PD-L1: a novel role of pro-survival signalling in cancer
Author:
Funder
NHMRC project
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/27/3/409/6677848/mdv615.pdf
Reference98 articles.
1. Adoptive immunotherapy for cancer: harnessing the T cell response;Restifo;Nat Rev Immunol,2012
2. Cancer immunotherapy comes of age;Mellman;Nature,2011
3. Immunotherapy and chemotherapy—a practical partnership;Lake;Nat Rev Cancer,2005
4. Adoptive cell transfer: a clinical path to effective cancer immunotherapy;Rosenberg;Nat Rev Cancer,2008
5. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010
Cited by 607 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment;Oral Oncology;2024-11
2. PD-L1 and PD-1 in immune regulation and their implications in blood cancers;Advances in Cancer Biology - Metastasis;2024-10
3. Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients;Basic Research in Cardiology;2024-09-03
4. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application;European Journal of Pharmacology;2024-09
5. Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance;Chemical Biology & Drug Design;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3